Chemokine and immunosuppressive molecule expression profiles can be used to accurately predict clinical responses, differentiating the patients who would and would not benefit from PD-1 or PD-L1 immunotherapies.https://t.co/TiP8PAEfLv https://t.co/fHjvVAU3
192 followers
62 followers
RT @CellworksLife: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.…
192 followers
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. #immunotherapy #lungcancer #NSCLC @uiowa @sloan_kettering @columbiacancer https://t.co/aPRV78dM2p https://t.co/GGVBn6NYQc
112 followers
#BMCCancer Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. https://t.co/wnk26QvzYt